home / stock / mrna / mrna articles

MRNA Articles, Moderna Inc. - From 07/02/24

Stock Information
Company Name: Moderna Inc.
Stock Symbol: MRNA
Market: NASDAQ
Website: modernatx.com
Menu
MRNA MRNA Quote MRNA Short MRNA News MRNA Articles MRNA Message Board
Get MRNA Alerts

News, Short Squeeze, Breakout and More Instantly...
London High Court Ruling Fuels Pfizer And Moderna Legal Dispute Over COVID-19 Vaccine Patents | Benzinga

Pfizer Inc. (NYSE:PFE) and Moderna Inc. (NASDAQ:MRNA) are set for more legal battles over their rival COVID-19 vaccines after London’s High C...
Amid Rapidly Rising Bird Flu Cases, Moderna Lands $176M Worth US Government Contract For Vaccine | Benzinga

In response to the growing threat of the H5N1 bird flu virus, the U.S. government has awarded a $176 million contract to Moderna Inc. (NASDAQ:MRNA)...

Moderna And Walgreens Boots Alliance Were Among The 10 Biggest Large Cap Losers Last Week (June 23 - June 29): Are These In Your Portfolio? | Benzinga

These ten large-cap stocks were the worst performers in the last week. Are they in your portfolio? Walgreens Boots Alliance, Inc. (NASDAQ:WBA) sh...

What's Going On With Moderna Stock Friday? | Benzinga

Moderna, Inc. (NASDAQ:MRNA) stock is trending on Friday. The company announced that the European Medicines Agency’s Committee for Medicinal P...
CDC Advisor Panel Recommends RSV Shots In US For People Above 75 Years, Analyst Says Decision Negative For GSK | Benzinga

On Wednesday, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted to recomm...

Why Is Moderna Stock Trading Lower On Wednesday? | Benzinga

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practice will meet this week to consider and recommend wh...

What's Going On With Eli Lilly Stock On Tuesday? | Benzinga

On Tuesday, Eli Lilly and Co (NYSE:LLY) announced a collaboration with Microsoft Corp (NASDAQ:MSFT)-backed OpenAI that will allow Lilly to lev...
$100 Invested In This Stock 5 Years Ago Would Be Worth $900 Today | Benzinga

Moderna (NASDAQ:MRNA) has outperformed the market over the past 5 years by 44.13% on an annualized basis producing an average annual return of 57.4...

Novavax Seeks FDA Nod for Updated COVID-19 Vaccine | Benzinga

Novavax (NASDAQ: NVAX) submitted an application to the FDA, seeking to amend its Emergency Use Authorization (EUA) and update its protein-based COV...

Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment | Benzinga

AstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug Administration for its ...
Previous 10 Next 10